Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 December 2021 | Story Dr Nitha Ramnath

The University of the Free State will present the December 2021 graduation ceremonies virtually from 8 to 13 December 2021. The recent changes in our environment due to the discovery of the Omicron variant, and the increase in COVID-19 infection rates in South Africa, have required us to re-assess our plans.  This was also addressed as a matter of concern by President Cyril Ramaphosa during the family meeting on 28 November 2021. 

After careful consideration of the risks of presenting face-to-face graduation ceremonies, the executive management of the University of the Free State (UFS) has decided to adjust all the ceremonies to virtual broadcasts. 

The university community acknowledges your hard work and achievements in the midst of the many challenges you have faced. Despite not being able to meet in person, we are grateful that technology makes it possible to proceed with this significant event. 

The graduation ceremonies will be broadcast as follows:

Faculty of Education, South Campus: Wednesday, 8 December 2021 at 09:00

Faculty of Education, South Campus graduands: Wednesday, 8 December 2021 at 11:00

Faculty of Education, Bloemfontein Campus and Qwaqwa Campus graduands: Thursday, 9 December 2021 at 09:00

Faculty of Economic and Management Sciences: Thursday, 9 December at 11:00

Faculty of Natural and Agricultural Sciences: Friday, 10 December at 09:00

Faculty of the Humanities: Friday, 10 December 2021 at 11:00

Faculties of Health Sciences, Law, and Theology and Religion: Monday, 13 December 2021 at 09:00

Congratulations to all our graduates; may you have continued success in all your endeavours! 

 


News Archive

Death may come in adorable little packages
2015-03-23

The main host of the Lassa virus is the Natal Mulimammate mouse.

Photo: Supplied

Postdoctoral researcher, Abdon Atangana, of the Institute for Groundwater Studies at the university recently published an article online about the Lassa Haemorrhagic fever in the Natural Computing Applications Forum. In addition to the terminal transmissible sickness recognised as Ebola haemorrhagic fever, there is another strain called Lassa haemorrhagic fever.

The disease is classified under the arenaviridae virus family. The first outbreaks of the disease were observed in Nigeria, Liberia, Sierra Leone, and the Central African Republic. However, it was first described in 1969 in the town of Lassa, in Borno State, Nigeria.

The main host of the Lassa virus is the Natal Mulimammate mouse, an animal indigenous to most of Sub-Saharan Africa. The contamination in humans characteristically takes place through exposure to animal excrement through the respiratory or gastrointestinal tracts.

Mouthfuls of air containing tiny particle of infective material are understood to be the most noteworthy way of exposure. It is also possible to acquire the infection through broken skin or mucous membranes that are directly exposed to the infective material.

“The aim of my research was to propose a novel mathematical equation used to describe the spread of the illness amongst pregnant women in West Africa. To achieve this, I used my newly-proposed derivative with fractional order called beta-derivative. Since none of the commonly used integral transform could be used to derive the solution of the proposed model, I proposed a new integral transform called Atangana-Transform, and used it, together with some iterative technique, to derive the solution of the model.

“My numerical simulations show that the disease is as deadly amongst pregnant women as Ebola,” Abdon said.

Abdon’s research was submitted to one of Springer’s top-tier journals with an impact factor 1.78. The paper was accepted and published February 2015.

Read more about Abdon’s research.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept